Fiduciary Trust Co Acquires 738 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Trust Co increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 69,828 shares of the healthcare conglomerate’s stock after purchasing an additional 738 shares during the quarter. Fiduciary Trust Co’s holdings in UnitedHealth Group were worth $35,323,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors grew its holdings in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH stock opened at $385.74 on Friday. UnitedHealth Group Incorporated has a 1 year low of $385.37 and a 1 year high of $630.73. The stock’s fifty day moving average price is $489.89 and its 200-day moving average price is $523.90. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $351.11 billion, a P/E ratio of 24.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company posted $6.91 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

Analysts Set New Price Targets

A number of brokerages recently commented on UNH. Royal Bank of Canada dropped their price target on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird decreased their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Truist Financial decreased their price objective on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a report on Monday, April 21st. Finally, Oppenheimer reduced their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, April 21st. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.